EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in noncanonical inhibition mechanisms of anti‐CRISPR proteins

Lingguang Yang, Rongjun Luo, Wei Zhou, Peipei Yin, Yue Feng iD, Yi Zhang iD

mLife · 2026-04 · 5 (2) · 133-147

DOI: 10.1002/mlf2.70077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift mLife, online erschienen am 10.04.2026. Verfasst von Lingguang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yichun University Center for Innovative Technologies in Gene-Based Precision Therapeutics, School of Pharmacy Yichun University Yichun China. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CRISPR‐Cas system constitutes an adaptive immune mechanism in prokaryotes that defends against mobile genetic elements. Within the perpetual co‐evolutionary arms race between bacteria and their viral predators, bacteriophages encode anti‐CRISPR (Acr) proteins that use sophisticated molecular strategies to sabotage CRISPR‐Cas function. While canonical Acr proteins rely on steric blockade of Cas effectors, recent discoveries reveal unprecedented noncanonical mechanisms spanning CRISPR immunity stages. This review synthesizes recent mechanistic advances in this field since 2023, highlighting the expansion of noncanonical inhibition mechanisms beyond type I to include types II, V, and VI, as well as novel Acr interventions targeting multiple functional stages, such as spacer acquisition, translation‐coupled inhibition, complex assembly/disassembly, and R‐loop DNA binding. Structural insights demonstrate how Acr proteins achieve substoichiometric inhibition via conformational hijacking, catalytic repurposing, and molecular mimicry. Forged by the intense selective pressure of the phage–host conflict, these molecular innovations represent both remarkable evolutionary adaptations and versatile precision tools. They enable spatiotemporal control of CRISPR technologies, from engineered off‐switches to diagnostic reset mechanisms, while posing critical challenges for therapeutic safety and microbiome management.

Schlagwörter

Stichwörter der Autor:innen

CRISPR‐Casanti‐CRISPRnoncanonical inhibitionphage–host arms racestructural mechanism

Autor:innen und Institutionen

  • Yichun University Center for Innovative Technologies in Gene-Based Precision Therapeutics, School of Pharmacy Yichun University Yichun China.
  • Bloomage Biotechnology Co. Ltd. Jinan China.
  • State Key Laboratory of Green Biomanufacturing, College of Life Science and Technology Beijing University of Chemical Technology Beijing China.

ORCID-Profile: Yue Feng, Yi Zhang

Förderung

  • Natural Science Foundation of Jiangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Yang, L., Luo, R., Zhou, W., Yin, P., Feng, Y., & Zhang, Y. (2026). Recent advances in noncanonical inhibition mechanisms of anti‐CRISPR proteins. mLife, 5(2), 133-147. https://doi.org/10.1002/mlf2.70077

Vancouver

Yang L, Luo R, Zhou W, Yin P, Feng Y, Zhang Y. Recent advances in noncanonical inhibition mechanisms of anti‐CRISPR proteins. mLife. 2026;5(2):133-147. doi:10.1002/mlf2.70077

BibTeX
@article{Yang2026,
  author = {Yang, Lingguang and Luo, Rongjun and Zhou, Wei and Yin, Peipei and Feng, Yue and Zhang, Yi},
  title = {Recent advances in noncanonical inhibition mechanisms of anti‐CRISPR proteins},
  journal = {mLife},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {133--147},
  doi = {10.1002/mlf2.70077}
}
Kostenlos starten →